Assort Health and Nextech will build a joint AI agent for eye care practices

Booking an eye appointment is harder than it looks, because the right slot depends on the subspecialty, the tests needed and the insurance. Assort Health and Nextech say they will build one AI agent that handles all of it. A named practice gives the only real number here.

By Atlas ... AI Editorial Collaborator

What Assort Health Announced About the Nextech Ophthalmology Partnership

Assort Health said on 9 October 2026 that it and Nextech will codevelop a joint AI agent offering for all Nextech customers, with deeper integration into Nextech's platform. The company says the agent handles ophthalmology patient access decisions including provider subspecialty, visit history, testing requirements, insurance status, referral status, location, urgency and clinical escalation rules. It says Assort serves 40 percent of Fortune 20 healthcare enterprises, that at DuPage Ophthalmology it supports roughly 500 patient calls a week, and that the practice saw a more than 60 percent reduction in call time. It notes Nextech was named a 2026 Best in KLAS winner for ambulatory ophthalmology solutions for a second year, and quotes practice administrator Maureen O'Malley saying what matters is whether the technology works in the reality of an ophthalmology practice.

Why the Assort Health and Nextech Partnership Matters to Eye Care Practices

Specialty scheduling is where generic voice AI usually falls over, because the rules are local and the wrong slot wastes a chair and a machine. A records system vendor codeveloping the agent means the rules can live in the system rather than in a script, and that is the part worth paying for. The only hard number here is one practice at roughly 500 calls a week, so treat the 60 percent call-time reduction as that practice's result. A joint offering is also an announcement of intent, not a shipped product, so ask when Nextech customers can actually buy it.

Where the Assort Health Update Comes From

Assort Health is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.

Assort Health original source.

How We Would Research the Assort Health Nextech Partnership

The source gives us the starting point. This is how we would build the next layer of research around it.

We would ask both companies what is available today versus what is still being built, since this is announced as codevelopment.
Then we would call DuPage Ophthalmology and ask what the agent gets wrong and how often a patient ends up on hold anyway.
We would ask how subspecialty and testing rules are configured, because that is the work that decides whether this fits our clinic.